-transparent.png){kind=logo}
An in vivo radioligand binding assay for the N-methyl-D-aspartate (NMDA) receptor channel complex in the mouse brain has been developed using the non-competitive NMDA receptor antagonist [3H]MK-801. In vivo binding of [3H]MK-801 was displaced by MK-801 (ED50 = 0.17 mg/kg i.p.), (-)-MK-801 (1.0 mg/kg), thienylcyclohexylpiperidine (1.8 mg/kg), etoxadrol (5.1 mg/kg) and (+)-SKF 10,047 (34.5 mg/kg). The potency of these drugs in this in vivo binding assay was highly correlated (r = 0.97) with their functional effects as antagonists of N-methyl-DL-aspartate-induced tonic convulsions.
Related Publications
G W Price, and
R G Ahier, and
D N Middlemiss, and
L Singh, and
M D Tricklebank, and
E H Wong
April 2018,
Nature,
G W Price, and
R G Ahier, and
D N Middlemiss, and
L Singh, and
M D Tricklebank, and
E H Wong
September 1990,
European journal of pharmacology,
G W Price, and
R G Ahier, and
D N Middlemiss, and
L Singh, and
M D Tricklebank, and
E H Wong
October 1987,
European journal of pharmacology,
G W Price, and
R G Ahier, and
D N Middlemiss, and
L Singh, and
M D Tricklebank, and
E H Wong
April 1992,
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology,
G W Price, and
R G Ahier, and
D N Middlemiss, and
L Singh, and
M D Tricklebank, and
E H Wong
December 1991,
Pharmacology, biochemistry, and behavior,
G W Price, and
R G Ahier, and
D N Middlemiss, and
L Singh, and
M D Tricklebank, and
E H Wong
June 2000,
European journal of pharmacology,
G W Price, and
R G Ahier, and
D N Middlemiss, and
L Singh, and
M D Tricklebank, and
E H Wong
May 1994,
Neuroreport,
G W Price, and
R G Ahier, and
D N Middlemiss, and
L Singh, and
M D Tricklebank, and
E H Wong
October 1997,
Brain research,
G W Price, and
R G Ahier, and
D N Middlemiss, and
L Singh, and
M D Tricklebank, and
E H Wong
September 1997,
Pharmacology, biochemistry, and behavior,
G W Price, and
R G Ahier, and
D N Middlemiss, and
L Singh, and
M D Tricklebank, and
E H Wong
May 1994,
Psychopharmacology,
